David J. Einstein

MedicineComputer Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer”.

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0.825DataRank · unranked

244 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-21-1807

N/A

0.553DataRank · unranked

39 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

A phase 2 study of berzosertib (M6620) in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5034

N/A

0.461DataRank · unranked

8 citations

Wanling Xie, Edmund Folefac, Daniel Lee, Mamta Parikh, David J. Einstein +12 more

BH3 mimetics targeting BCL-XL have efficacy in solid tumors with RB1 loss and replication stress

Nature Communications(2025)10.1038/s41467-025-60238-x

N/A

0.417DataRank · unranked

12 citations

Keshan Wang, Mannan Nouri, N. V. Kozlova, Daniel R. Schmidt, Anastasia Stavridi +27 more

The Potential Role for Immunotherapy in Biochemically Recurrent Prostate Cancer

Urologic Clinics of North America(2020)10.1016/j.ucl.2020.07.004

N/A

0.373DataRank · unranked

11 citations

David J. Einstein, Fatima Karzai, William L. Dahut, James L. Gulley, Jeanny B. Aragon‐Ching +2 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

medRxiv(2021)10.1101/2021.01.27.21250464

N/A

0DataRank · unranked

4 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

Cancer Research(2022)10.1158/0008-5472.can-22-1533

N/A

0DataRank · unranked

22 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Polo-like kinase-1 Inhibitors and the Antiandrogen Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.05.12.491633

N/A

0DataRank · unranked

0 citations

Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri +14 more

Does Use of Information Sources Outside the Treating Oncologist Influence Patient Decision-Making in Patients Receiving Non-Curative Intent Therapy for Advanced Cancer

American Journal of Hospice and Palliative Medicine®(2022)10.1177/10499091221134531

N/A

0DataRank · unranked

0 citations

Eric J Miller, David J. Einstein, Laura E. Dodge, Jennifer Halleck, Mary K. Buss +1 more

FORMULA-509: A Multicenter Randomized Trial of Post-Operative Salvage Radiotherapy (SRT) and 6 Months of GnRH Agonist with Either Bicalutamide or Abiraterone Acetate/Prednisone (AAP) and Apalutamide (Apa) Post-Radical Prostatectomy (RP)

International Journal of Radiation Oncology*Biology*Physics(2023)10.1016/j.ijrobp.2023.06.401

N/A

0DataRank · unranked

3 citations

Marisa Kollmeier, Dana E. Rathkopf, Richard M. Hoffman, A. Zurita-Saavedra, Daniel E. Spratt +15 more

Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.01.012

N/A

0DataRank · unranked

3 citations

Laura E. Dodge, Peter Chang, David J. Einstein, Daniel Sentana‐Lledo

Treatment-free survival (TFS) outcomes from the phase II study of nivolumab and salvage nivolumab + ipilimumab in advanced clear cell renal cell carcinoma (aRCC) (HCRN GU16-260-Cohort A).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.604

N/A

0DataRank · unranked

5 citations

Opeyemi A. Jegede, David F. McDermott, Naomi B. Haas, Mehmet Asım Bilen, Mark N. Stein +11 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

(2023)10.1158/1078-0432.c.6530387.v1

N/A

0DataRank · unranked

0 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Data from Autocrine Canonical Wnt Signaling Primes Noncanonical Signaling through ROR1 in Metastatic Castration-Resistant Prostate Cancer

(2023)10.1158/0008-5472.c.6513813.v1

N/A

0DataRank · unranked

0 citations

Seiji Arai, Keshan Wang, Carla Calagua, Amanda R. Yuan, Larysa Poluben +12 more

Biochemically recurrent prostate cancer in the era of EMBARK and PSMA PET imaging: everything has changed, except the patients

Current Opinion in Oncology(2024)10.1097/cco.0000000000001030

N/A

0DataRank · unranked

10 citations

Jeanny B. Aragon‐Ching, Fatima Karzai, Ravi A. Madan, David J. Einstein

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008293

N/A

0DataRank · unranked

6 citations

Opeyemi A. Jegede, Naomi B. Haas, David F. McDermott, Mehmet Asım Bilen, Mark N. Stein +11 more

AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer

Molecular Cancer Therapeutics(2024)10.1158/1535-7163.mct-23-0933

N/A

0DataRank · unranked

5 citations

Andreas Varkaris, Maya Ridinger, Susan L. Dalrymple, Christopher M. Dennehy, John T. Isaacs +4 more

Metastasis-Free Survival Versus Treatment-Free Survival in Biochemically Recurrent Prostate Cancer: The EMBARK Trial

Journal of Clinical Oncology(2024)10.1200/jco.24.00279

N/A

0DataRank · unranked

16 citations

Meredith M. Regan, Julia S. Stevens, David F. McDermott, Ravi A. Madan, David J. Einstein

Reply to B. Tombal et al

Journal of Clinical Oncology(2024)10.1200/jco-24-01595

N/A

0DataRank · unranked

0 citations

Meredith M. Regan, Julia S. Stevens, David F. McDermott, Ravi A. Madan, David J. Einstein

Androgen deprivation–mediated activation of AKT is enhanced in prostate cancer with TMPRSS2:ERG fusion

Journal of Clinical Investigation(2025)10.1172/jci192368

N/A

0DataRank · unranked

1 citations

Sen Chen, Luigi Cecchi, Betul Ersoy-Fazlioglu, Joshua W. Russo, Seiji Arai +16 more

A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5597

N/A

0DataRank · unranked

3 citations

Wanling Xie, Mamta Parikh, Daniel Lee, Elizabeth R. Kessler, David J. Einstein +8 more

A phase II study of M6620 in combination with carboplatin compared with docetaxel in combination with carboplatin in metastatic castration-resistant prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps252

N/A

0DataRank · unranked

0 citations

Wanling Xie, Mamta Parikh, Daniel Lee, Elizabeth R. Kessler, David J. Einstein +8 more

A Subset of Localized Prostate Cancer Displays an Immunogenic Phenotype Associated with Losses of Key Tumor Suppressor Genes

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-0121

N/A

0DataRank · unranked

48 citations

Miriam Ficial, Caroline S. Jansen, Taghreed Hirz, Luke del Balzo, Scott Wilkinson +12 more

Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors

JCO Precision Oncology(2021)10.1200/po.21.00059

N/A

0DataRank · unranked

17 citations

Seiji Arai, Carla Calagua, Fang Xie, Olga Voznesensky, Brian J. Capaldo +6 more